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Introduction: Open repair of ruptured abdominal aortic aneurysm (rAAA) still has a high mortality. Endovascular aortic
repair (EVAR) may be the way to improve survival rates. However, it is not clear how many patients with rAAA will be
suitable for acute EVAR.
Methods: Between October 2000 and April 2002 all patients with acute symptomatic or ruptured AAA were assessed for
EVAR on an intention-to-treat basis with emergency computed tomographic angiography (CTA). Patient and logistic
characteristics were analysed. We used two commercially available aorto uni-iliac devices with a maximum proximal
diameter of 28 and 34 mm.
Results: Five out of 26 patients were excluded for CTA and EVAR because of severe and persistent hypotension (3 pts) or
logistic reasons (2 pts, both eligible). Twelve patients were found not eligible for EVAR due to unsuitable infrarenal aortic
neck length (3 pts), neck diameter (1 pt) or a combination of both (8 pts). The remaining six patients were treated with EVAR.
After 6 months no graft failure or aneurysm related deaths were recorded in the EVAR group.
Conclusion: A total of 28% of patients with symptomatic or ruptured AAA was treated with EVAR. A potential 42% of
patients could have been suitable for EVAR, if the correct devices had been in stock and all patients had been properly
assessed.
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Introduction
Basic surgical techniques and outcome for ruptured
abdominal aortic aneurysm (rAAA) repair have
changed little during the last decades. Despite
improved intra and postoperative care, rAAA still
has a poor prognosis with an excessive hospital
mortality estimated as high as 41%1 with significant
associated morbidity. This is in accordance with our
own figures; the yearly mortality in our hospital
during the last 5 years of open repair for rAAA varied
between 33 and 55%.
Endovascular aortic repair (EVAR) in elective
abdominal aortic aneurysm (AAA) surgery has pro-
ven to be technically feasible and safe with interesting
improvements in short-term outcome.2,3 We have a 5-
year experience with elective EVAR in more than 100
patients. No major events have taken place in the
follow-up, i.e. no aneurysm rupture or graft related
mortality. Our hospital mortality in elective EVAR is
1.8%.
In search of techniques to improve the persistent
moderate results of open rAAA repair acute EVAR
could have potential advantages. It avoids major
surgical exposure and can be performed under local
anaesthesia with less physical stress and minimal
blood loss.4 – 6
We started a study in which patients with acute
symptomatic AAA (sAAA) or rAAA were assessed for
EVAR. The main objective was to investigate what
number of patients was eligible for EVAR applying our
strict anatomic criteria for elective EVAR using an
aorto uni-iliac (AUI) endograft with a contra-lateral
occluder and femorofemoral cross-over bypass.
Methods
During an 18-month period (October 2000– April
2002) all consecutive patients presenting with the
clinical diagnosis of acute sAAA or rAAA at the
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Accident and Emergency Department (AED) of our
hospital were assessed for possible emergency EVAR
on base of an intention-to-treat protocol. Approval of
this protocol by the local ethics committee was
obtained. The in- and exclusion criteria are described
in Table 1. Resuscitation with limited fluid infusion
and even nitroprusside was performed to keep the
systolic blood pressure stable around 80 mmHg until
the aneurysm was excluded. Unstable patients with
persistent systolic blood pressure lower than
80 mmHg, indicating a free intra-abdominal rupture
of the aneurysm, were excluded for computed tomo-
graphic angiography (CTA) and consequently for
EVAR in this study.
Patient characteristics, risk factors and co-morbidity
according to the Society for Vascular Surgery/North
American Chapter of the International Society for
Cardiovascular Surgery (SVS/ISCVS), spiral CTA
measurements, elapsed time between admission and
start of operation, logistics, and intra- and post-
operative course of the EVAR cohort were recorded.
Characteristics and outcome of EVAR and open repair
for rAAA were compared.
After emergency clinical assessment at the AED, the
patient was immediately transferred for CTA of the
abdominal aorta and iliac vessels. In the first run, plain
8 mm slices of the descending aorta and iliac arteries
were made. If the diagnosis of (ruptured) AAA was
confirmed and EVAR seemed applicable, 100 ml
(2.5 ml/s) of intravenous contrast (Visapaquee 320,
Amersham cygne BV, Eindhoven, The Netherlands)
was administered. Thirty seconds after contrast infu-
sion 4 mm slices were made of the abdominal aorta
and the iliac arteries to assess the exact morphology of
the aneurysm. The total scanning time was less then
10 min. The plain and contrast enhanced CTA were
reviewed ‘online’ by a vascular surgeon and an
interventional radiologist. Our anatomical selection
criteria used for elective EVAR were also used for
emergency EVAR (Table 2).
Immediately after the scan was performed, the
patient was transported to the operating suite. The
patient was prepared and draped for a potential
emergency abdominal approach.
At the beginning of this study only the AneuRx
AUI (Medtronic AVE, Santa Rosa, CA, USA) was
available (maximum diameter of the main body of
28 mm), which is suitable for a maximum neck
diameter of the aneurysm of 25 mm. During the last
6 months of the study the so-called Talent emer-
gency AUI kit (Medtronic AVE, Santa Rosa, CA,
USA) with a bare suprarenal fixation spring became
available (maximum diameter of the main body
34 mm), stretching the maximum acceptable neck
diameter of the aneurysm to 30 mm.7
The EVAR procedure was started with a femoral
cutdown on both sides. The common femoral artery
was exposed. If the blood pressure decreased below
50 mmHg a supracoeliac aortic occlusion balloon was
introduced via the contra-lateral femoral artery. The
AUI stent was introduced via the femoral artery up to
the level of L1 over a stiff wire (Back-up Meier 185 cm,
0.89 mm, Boston Scientific, Miami, FL, USA), in the
Table 1. Entrance criteria pilot study.
Inclusion criteria
Patient is within the rAAA category as follows
Elective aneurysm s/rAAA Free rupture
Symptomatic Contained rupture Retroperitoneal Intra-abdominal
Recruitment of interest
Elective No symptoms
Symptomatic Painful aneurysm, no rupture on CTA, which needs urgent evaluation and emergency repair,12 h
Contained rupture Hemodynamically stable, with proven haematoma outside the aneurysmal sac
Free retroperitoneal rupture Hemodynamically stable, BP .80 mmHg systolic
Free intra-abdominal rupture Hemodynamically instable—should be excluded from this feasibility study
Exclusion criteria
CTA not available
Contrast allergy
Table 2. Anatomic criteria EVAR for AneuRx (A) or Talent (T) AUI.
Infrarenal neck
Absolute
1. Length $10 mm (A) and $8 mm (T)
2. Diameter #25 mm (A) and #30 mm (T)
Relative
1. Thrombus #40% of the circumference
2. Calcification #80% of the circumference
3. Infrarenal neck angulation #908
Iliac arteries
1. Suitable for access of main
delivery system on ipsilateral side
2. Suitable for sealing and fixation
on ipsilateral side at the level
of the common or the external
iliac artery.
3. Suitable for common iliac artery
occlusion on the contra-lateral side
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contra-lateral femoral artery a straight flush catheter
(Soft VU Straight flush 5F, 65 cm, Angiodynamics,
Queenbury, NY, USA) was introduced and also placed
at the level of L1. The first angiography was then
performed visualizing the renal arteries. The proximal
4 cm of the AUI was deployed and the upper part of
the covered graft was pulled down and positioned
exactly below the most distal renal artery. This
position was assessed with a second angiogram.
Thereafter the main body was deployed completely;
the straight flush catheter was pulled back into the
distal aorta and the sealing areas were ballooned if
appropriate. An ipsilateral iliac extension was placed
when sealing and fixation in the common iliac artery
area seemed insufficient. In case of the Talent 2-part
stent graft the limb was placed in the proximal device
component. The contra-lateral common iliac artery
was marked with the straight flush catheter and
thereafter occluded using an occlusion device. After
the stent graft was expanded, an angiogram was made
to confirm the appropriate position of the graft and
complete exclusion of the rAAA. The procedure was
completed with revascularisation of the contra-lateral
leg with a 6 or 8 mm femorofemoral cross-over tube
graft. A CTA was planned on the fifth postoperative
day.
Results
A total of 26 patients presented with the clinical
diagnosis of rAAA (25 pts) or acute symptomatic AAA
(1 pt) (Fig. 1). The characteristics on admission of these
26 patients are scheduled in Table 3. In five patients
CTA was not performed; three patients were hemo-
dynamically unstable on admission and had an
emergency laparotomy without delay, one patient
was not included because the endovascular team
was not notified and in one patient the appropriate
endovascular device was out of stock. While perform-
ing open repair we observed that EVAR would have
been possible in these last two patients with both
devices.
Emergency CTA evaluation was performed in the
remaining 21 patients. In 20 patients the diagnosis
contained that rAAA was confirmed; one patient had a
symptomatic AAA with contrast filled tears in the
thrombus. The CTA characteristics of the aneurysm
are listed in Table 4. A total of six patients were
accepted for emergency EVAR. The AneuRx AUI stent
graft was used in five patients and the Talent AUI stent
graft in one. The remaining 12 patients were not
eligible for EVAR due to infrarenal aortic neck length
(3 pts), infrarenal aortic neck diameter (1 pt) or a
combination of neck length and neck diameter (8 pts).
Two of these 12 patients were not treated because of
severe cardiopulmonary co-morbidity. All aneurysms
were excluded successfully and no endoleaks were
detected at the end of the EVAR procedures.
We encountered serious intra-operative hemody-
namic problems in the two EVAR patients treated
under general anaesthesia, whereas the next four
EVAR patients treated under local anaesthesia had
no problems. Postoperatively these two patients
needed prolonged artificial ventilator support due to
high intra-abdominal pressure, which was monitored
by measuring the urinary bladder pressure.8 In one of
these patients a large intra-abdominal haematoma
Fig. 1. Flowchart of 26 patients presenting with symptoms of sAAA or rAAA.
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Table 3. Characteristics on admission of 26 consecutive patients presenting with sAAA or rAAA.
Patient Age
(yrs)
Sex SVS/ISCVS risk score Systolic BP on arrival
(mmHg)
Hemoglobine on admission
(mmol/l)
Serum creatinine on admission
(mmol/l)
CTA Reason exclusion
1 75 M 3 .120 8.0 180 Y
2 58 M 5 .120 8.4 115 Y
3 71 M 0 90 8.1 114 Y
4 68 F 5 .120 6.9 111 Y
5 78 M 5 .120 7.8 156 Y
6 73 M 1 .120 5.6 900* Y
7 68 M 0 .120 6.8 93 Y
8 76 M 2 90 5.8 170 Y
9 55 M 0 .120 5.6 94 Y
10 78 F 2 .120 9.4 91 Y
11 80 M 4 .120 9.2 200 Y
12 81 M 2 100 9.0 190 Y
13 71 M 2 115 7.2 142 Y
14 71 M 3 80 7.3 136 Y
15 73 M 1 160 6.0 93 Y
16 48 M 3 120 7.0 131 Y
17 76 M 2 ,80 6.9 148 N Unstable low BP
18 60 M 3 100 8.4 128 Y
19 85 M 3 100 6.1 116 Y
20 71 M 0 .120 6.2 150 N EVAR team not available
21 66 M 0 .120 7.7 90 N Endograft not available
22 66 M 2 ,80 9.6 106 N Unstable low BP
23 69 M 3 .120 9.6 87 Y
24 76 M 2 220 9.3 68 Y
25 81 M 0 ,80 6.7 110 N Unstable low BP
26 75 F 4 80 6.2 102 Y
After EVAR 2 double J catheters were placed for a period of 3 months.
*This patient had a large retroperitoneal haematoma, compressing both ureters.
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Table 4. Results of CTA in 21 patients with clinical sAAA or rAAA.
Patient D2aa
(mm)
D2ba
(mm)
D2ca
(mm)
D3a
(mm)
H1a
(mm)
Angulation infrarenal neck Thrombus % of circumference Calcification % of circumference Shapeb of the infrarenal neck EVAR
1 24 30 30 68 28 ,45 10 10 II No‡
2 30 30 31 90 ,8 ,45 0 0 I No
3 20 20 21 90 20 90 0 0 I AneuRx
4 20 20 20 65 15 90 0 0 I AneuRx
5 34 34 34 88 0 ,45 0 0 I No
6 20 20 20 30 20 ,45 0 0 I AneuRx
7 34 36 38 70 ,8 ,45 0 10 II No
8 41 42 44 70 ,8 ,45 0 0 II No
9 28 32 34 57 ,8 ,45 20 0 II No
10 30 33 34 190 ,8 ,45 100 0 II No
11 24 26 28 85 ,8 ,45 60 20 II No
12 28 28 31 78 ,8 ,45 40 10 II No
13 25 30 30 98 36 ,45 20 10 II No‡
14 23 26 28 110 30 60 0 60 II No‡
15 18 22 23 60 17 ,45 0 10 II AneuRx
17 32 32 32 73 0 ,45 0 0 I No
18 25 25 25 74 ,8 80 0 40 I No
22 24 28 30 58 16 ,45 0 0 II Talent
23 21 21 23 82 48 ,45 0 0 II AneuRx
24 25 25 25 86 ,8 ,45 0 0 I No
26 28 30 32 78 9 100 0 0 II No
*Measurements in accordance to Eurostar.
†Shape in accordance to Balm et al.11
‡EVAR is possible using Talent AUI emergency kit.
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caused an abdominal compartment syndrome with
increased pulmonary peak pressure, oliguria and
urinary bladder pressure above 20 cm H2O. We
performed a laparotomy on the first postoperative
day to evacuate the intra-abdominal haematoma.
Unfortunately this did not immediately improve his
condition. The patient was weaned from ventilatory
support on the 19th postoperative day. This patient
died unexpectedly the day before discharge (30th
postoperative day) due to cardiac arrhythmia.
There was a clear tendency to diminished blood loss
and blood replacement, ICU stay, hospital stay, and
mortality in the EVAR group (Table 5). On CTA before
discharge one patient had a small type 2 endoleak
from a lumbar artery, the other aneurysms were
excluded completely.
Six to 24 months of follow-up is available in the five
surviving EVAR patients (Table 6). The diameter (D3)
of the AAAs was stable (1 pt with type 2 lumbar
endoleak) or clearly decreased (4 pts). One additional
endovascular procedure was necessary to exclude a
growing iliac aneurysm. One patient died due to
pulmonary insufficiency not related to the aneurysm 8
months postoperatively.
Discussion
Using our strict criteria for EVAR for the AneuRx AUI
stent graft 24% of the patients with acute sAAA or
rAAA were suitable for EVAR. This figure is consider-
ably lower than cited in some publications,9 but we
emphasize that the group in this study is an unselected
group. There was only one referred patient, who had a
juxtarenal aneurysm. This is demonstrated by the fact
that the number of patients with sAAA or rAAA that
was suitable for EVAR corresponds with the number
of elective patients that is suitable for EVAR in our
hospital using an AneuRx bifurcation endograft. A
potential 11 out of 26 patients (42%) presenting with
sAAA or rAAA could have been eligible for EVAR
with the Talent AUI emergency kit, an AUI device
with a largest proximal diameter of 34 mm. A majority
of patients were not suitable for EVAR due to an
inappropriate aortic neck length. Consequently,
further enlarging the proximal graft diameter will
not importantly increase the amount of patients
suitable for EVAR. In our opinion further reducing
the minimal acceptable aortic neck length for acute
EVAR below 8 mm will significantly increase the
chance of proximal type 1 endoleak on short term.
This type 1 endoleak will result in persistent bleeding
in an unstable patient. Conversion to open repair is a
hazardous procedure as it is accompanied by an
increased mortality, even in elective patients.10
In all rAAA and sAAA patients we used an aorto
uni-iliac system with femorofemoral cross-over graft.
The introduction and deployment of an AUI device is
rapid and relatively simple, leading to a swift
exclusion of the bleeding aneurysm. In our experience
with EVAR in elective AAA patients the cannulation of
the contra-lateral gate is possible within 5 min in a fast
majority of the patients. However, in 16% of our
elective EVAR procedures the cannulation time
exceeds 20 min, which can result in prolonged bleed-
ing in unstable patients with rAAA. Therefore an AUI
device is the appropriate choice in patients with
rAAA.
The number of patients presented here are small
and no statistical claims can be made. However, the
mortality in the EVAR group was remarkably low 17%
(1/6). The exclusion of the rAAA was clinically
successful in all patients. We only had one type 2
endoleak in the EVAR group not needing endovas-
cular exclusion so far. Although these figures make
emergency EVAR interesting we also encountered new
problems.
Firstly, two patients had prolonged respiratory
problems due to abdominal compartment syndrome
caused by a large intra-abdominal and retroperitoneal
haematoma. This is probably due to relaxation of
abdominal muscle tone in general anaesthesia with
subsequent free intraperitoneal rupture of the con-
tained rAAA. Swift exclusion of the aneurysm and/or
the use of an occlusion balloon can prevent excessive
bleeding. Local or locoregional anaesthesia seems
preferable instead of general anaesthesia.6 Another
option could be to start with local anaesthesia until the
Table 5. Intra and postoperative characteristics of 21 patients with sAAA or rAAA evaluated with CTA for EVAR.
EVAR (6 pts) Open repair (13 pts) No therapy (2 pts)
Operation time Mean (range) in min 163 (120–200) 132 (80–280) –
Blood loss Mean (range) in ml 300 (200–2000) 4500 (500–14,000) –
Blood replaced Mean (range) in ml 0 (0–3600) 1600 (0–4000) –
ICU stay Mean (range) in days 2,25 (0–27) 13 (2–40) –
Hospital stay Mean (range) in days 8 (5–36) 29 (9–121) –
Mortality* Number of pts 1 4 2
*Total mortality open repair group is 7/18 (4/13 pts with CTA and 3/5 pts without CTA).
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aneurysm is excluded, and then continuing the
procedure under general anaesthesia.7 Measuring
urinary bladder pressure can assess intra-abdominal
pressure. If the intra-abdominal pressure is higher
than 20 cm H2O and there is increased pulmonary
peak pressure with oliguria, a laparotomy should be
considered to decrease pressure.8
Secondly, CTA screening of rAAA costs extra
time before operation and can impose risks. Scan-
ning time is approximately 10 min, but transport
and transfers can cause an extra delay of approxi-
mately 15–20 min. Of course preparing the oper-
ation suite takes time as well. We did not encounter
adverse effects in our study, but we scanned only
patients who were relatively stable.
Thirdly, renal insufficiency can be induced by
contrast enhanced CTA and the EVAR procedure.
During CTA we administered 100 ml contrast
intravenously. During EVAR a mean of 195 ml
contrast was used. In our small group of patients
we saw only marked increase in creatinine levels
postoperatively in two patients, both treated with
open surgery and suprarenal clamping of the aorta.
There was no renal insufficiency in the EVAR group.
Fourthly, considering logistics we encountered
problems in two cases. In one patient the appro-
priate AneuRx stent grafts were not available, in the
second patient the endovascular team was not
notified due to unawareness of AED personnel
with the EVAR protocol. With the introduction of
the so-called Talent emergency kit, the first problem
is tackled. All main bodies are compatible with all
extensions, thereby reducing the stock that is
necessary to treat rAAA, which will also decrease
the financial burden. We believe that extensive
EVAR protocol training of the AED and operating
room personnel including the endovascular team
will make EVAR feasible in 40–50% of the patients
with rAAA.
A randomised trial between EVAR and open repair
is necessary to demonstrate an improvement in
survival of rAAA repair. But even if the rAAAs with
the most favourable anatomy are treated with EVAR,
the results are thus encouraging9 that the overall
mortality can possibly drop in decades to come and
randomised trials may seem unethical.
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